One expert said the blood-clotting syndrome was estimated to occur in one in 50,000 people under 40 and one in 100,000 over 40 who received AstraZeneca’s vaccine.
Tag: Blood Clots
AstraZeneca’s Covid Vaccine May Have Posed a Higher Heart Risk for Young Women, Study Shows
A new analysis examined deaths in Britain, where the company’s product was restricted in 2021 because of safety concerns.
C.D.C. Recommends Pfizer or Moderna Vaccines Over J.&J
A committee of experts voted on a preference for the Moderna or Pfizer immunizations, citing the risk of blood clots linked to Johnson & Johnson’s product.
J.&J. Vaccine May Be Less Effective Against Delta, Study Suggests
Many who received the shot may need to consider boosters, the authors said. But federal health officials do not recommend second doses.
Italy Halts Use of AstraZeneca Vaccine for Those Under 60
The decision was the latest in a series of reversals for the vaccine, and Italian health experts fear damage to the country’s vaccination campaign.
AstraZeneca Shots Carry Slightly Higher Risk of Bleeding Problem, New Study Says
But the research, involving 2.53 million adults in Scotland, found that the vaccine’s benefits outweighed the small risks.
A Vaccine Side Effect Leaves Women Wondering: Why Isn’t the Pill Safer?
Scientists were alarmed by blood clots possibly linked to the J&J vaccine. Some women wondered if there shouldn’t be more concern about oral contraceptives.
U.K. Advises Offering Alternatives to AstraZeneca Vaccine for Under-40s
Its regulator factored in concerns over very rare blood clots, the dwindling risk of severe infection and the availability of alternatives.
J.&.J. Vaccine Will Be Available Again Soon
U.S. experts weigh the risks for younger women and cases of a rare blood-clotting disorder, and lift the pause in giving the one-shot vaccine.
A new study hints at a reason the J.&J. and AstraZeneca vaccines may cause blood clots in rare cases.
A panel of experts advising the Centers for Disease Control and Prevention is discussing rare blood clots that health officials have investigated in Johnson & Johnson coronavirus vaccine recipients.